National Association of Chain Drug Stores
Registered Principal Details
Business Or Interest:
chain drug stores, practice of pharmacy
Lobbying Interests:
Practice of pharmacy; Medicaid reimbursement; Pharmacy Examining Board; Prescription Drug Monitoring Program; pseudoephedrine precursor issues; controlled substances; Medication Therapy Management.
CEO Name:
Steve Anderson
Regional Director, State Government Affairs
chain drug stores, practice of pharmacy
Lobbying Interests:
Practice of pharmacy; Medicaid reimbursement; Pharmacy Examining Board; Prescription Drug Monitoring Program; pseudoephedrine precursor issues; controlled substances; Medication Therapy Management.
CEO Name:
Steve Anderson
Regional Director, State Government Affairs
Contact
JK
Joel Kurzman
2550 Crawford Avenue, Suite 22
Evanston, IL 60201
(847) 905-0555
(224) 534-0429
jkurzman@nacds.org
http://www.nacds.org
2550 Crawford Avenue, Suite 22
Evanston, IL 60201
(847) 905-0555
(224) 534-0429
jkurzman@nacds.org
http://www.nacds.org
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 445
Relating to: identification presentation and monitoring for certain prescription drugs. (FE)
Bill Text and History
2013 Wisconsin Act 199
12/18/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Comments
NACDS is committed to developing and implementing effective ways to curb diversion of prescription drugs. However, untargeted requirements are onerous to comply with and impose additional burdens without reducing the occurrence of diversion.
Supporting Documentation
20131218_024110_Mandatory Collection of Positive ID for Controlled Substances Prescriptions.doc
Relating to: identification presentation and monitoring for certain prescription drugs. (FE)
Bill Text and History
2013 Wisconsin Act 199
Against
Notification Date12/18/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Comments
NACDS is committed to developing and implementing effective ways to curb diversion of prescription drugs. However, untargeted requirements are onerous to comply with and impose additional burdens without reducing the occurrence of diversion.
Supporting Documentation
20131218_024110_Mandatory Collection of Positive ID for Controlled Substances Prescriptions.doc
Senate Bill 345
Relating to: the authority and responsibilities of the Department of Safety and Professional Services and the various boards under that department, the membership of the Cosmetology Examining Board, professional licensure of pharmacists, the Pharmacy Exami...
Bill Text and History
2013 Wisconsin Act 124
10/18/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the authority and responsibilities of the Department of Safety and Professional Services and the various boards under that department, the membership of the Cosmetology Examining Board, professional licensure of pharmacists, the Pharmacy Exami...
Bill Text and History
2013 Wisconsin Act 124
Other
Notification Date10/18/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 353
Relating to: identification presentation and monitoring for certain prescription drugs. (FE)
Bill Text and History
12/18/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Supporting Documentation
20131218_024649_Mandatory Collection of Positive ID for Controlled Substances Prescriptions.doc
Relating to: identification presentation and monitoring for certain prescription drugs. (FE)
Bill Text and History
Against
Notification Date12/18/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Supporting Documentation
20131218_024649_Mandatory Collection of Positive ID for Controlled Substances Prescriptions.doc
Administrative Rulemaking Proceedings
Agency Name
Pharmacy Examining Board (Phar)
Subject
Pharmacy practice.
Scope Statement
Register Number: 691 (7/15/2013)
10/18/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Pharmacy Examining Board (Phar)
Subject
Pharmacy practice.
Scope Statement
Register Number: 691 (7/15/2013)
Other
Notification Date10/18/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Agency Name
Pharmacy Examining Board (Phar)
Subject
Revise section Phar 7.015, relating to pharmacy technicians. SS 096-12
Scope Statement
Register Number: 684 (1/1/2013)
10/18/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Pharmacy Examining Board (Phar)
Subject
Revise section Phar 7.015, relating to pharmacy technicians. SS 096-12
Scope Statement
Register Number: 684 (1/1/2013)
Other
Notification Date10/18/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Revise sections Phar 7.08 (1), 8.05, 8.07 (2), and 8.09, relating to electronic prescriptions for schedule II controlled substances. SS 094-12
Agency Name
Pharmacy Examining Board (Phar)
Subject
Revise sections Phar 7.08 (1), 8.05, 8.07 (2), and 8.09, relating to electronic prescriptions for schedule II controlled substances. SS 094-12
Scope Statement
Register Number: 684 (1/1/2013)
10/18/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Pharmacy Examining Board (Phar)
Subject
Revise sections Phar 7.08 (1), 8.05, 8.07 (2), and 8.09, relating to electronic prescriptions for schedule II controlled substances. SS 094-12
Scope Statement
Register Number: 684 (1/1/2013)
For
Notification Date10/18/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Agency Name
Pharmacy Examining Board (Phar)
Subject
The administration of the prescription drug monitoring program.
Scope Statement
Register Number: 689 (5/15/2013)
10/18/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Pharmacy Examining Board (Phar)
Subject
The administration of the prescription drug monitoring program.
Scope Statement
Register Number: 689 (5/15/2013)
Other
Notification Date10/18/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
State-level implementation of federal Medicaid pharmacy reimbursement changes
State-level implementation of federal Medicaid pharmacy reimbursement changes
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/7/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/7/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2013 January - June $5,808.00 |
2013 July - December $3,649.00 |
2014 January - June $7,160.00 |
2014 July - December $7,006.50 |
Total $23,623.50 |
| Total Hours Communicating | 2013 January - June 19.00 |
2013 July - December 4.50 |
2014 January - June 6.00 |
2014 July - December 1.00 |
Total 30.50 |
| Total Hours Other | 2013 January - June 33.75 |
2013 July - December 27.00 |
2014 January - June 16.25 |
2014 July - December 14.00 |
Total 91.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: the authority and responsibilities of the Department of Safety and Professional Services and the various boards under that department, the membership of the Cosmetology Examining Board, professional licensure of pharmacists, the Pharmacy Examining Board's operation of the prescription drug monitoring program, authorizing the construction, installation, alteration, operation, and inspection of elevators and other similar conveyances, and licensing requirements for elevator mechanics, inspectors, and contractors. (FE)
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June |
2013 July - December 5% |
2014 January - June 5% |
2014 July - December |
Total 2% |
Relating to: identification presentation and monitoring for certain prescription drugs. (FE)
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June |
2013 July - December 5% |
2014 January - June 5% |
2014 July - December |
Total 2% |
Relating to: identification presentation and monitoring for certain prescription drugs. (FE)
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June |
2013 July - December 65% |
2014 January - June 65% |
2014 July - December 45% |
Total 34% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June |
2013 July - December 5% |
2014 January - June 5% |
2014 July - December 5% |
Total 3% |
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June |
2013 July - December 5% |
2014 January - June 5% |
2014 July - December 5% |
Total 3% |
Revise sections Phar 7.08 (1), 8.05, 8.07 (2), and 8.09, relating to electronic prescriptions for schedule II controlled substances. SS 094-12
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June |
2013 July - December 5% |
2014 January - June |
2014 July - December |
Total 2% |
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June |
2013 July - December 10% |
2014 January - June 15% |
2014 July - December 45% |
Total 11% |
Topics Not Yet Assigned A Bill Or Rule Number
No topics found.
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
No other matters found.